You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
三葉草生物-B(02197.HK)與Genhunter版稅費將於下一份年報披露
阿思達克 12-28 09:05
三葉草生物-B(02197.HK)公布,有關GenHunter同意根據有關Trimer-Tag技術平台的專利及專利申請、商標及版權(統稱GenHunter知識產權)在全球及所有生物藥品及研發應用領域授予公司全資附屬四川三葉草獨家許可,據此,產品開始首次商業銷售或收到分許可收入後,集團須於截至12月31日止各曆年結束後60天內提交版稅報告,並於報告提交後向Genhunter支付版稅費。 截至目前,公司尚未獲得截至今年12月31日止年度版稅費。版稅費將於今年12月31日後60日內遞交予Genhunter的版稅報告中對賬,並將於截至今年12月31日止年度公司下一份年報內披露。 此外,公司向聯交所申請豁免嚴格遵守上市規則第14A.53條的期限延長三年至2026年12月31日止,並獲聯交所批准。公司指出,截至目前,公司過往產品銷售額遠不足以作為制定許可協議項下未來三個財政年度金額上限的指標;就產品的潛在銷量及/或分許可收入實施任意上限不具商業合理性,且就集團、GenHunter以及彼等各自股東的利益而言會產生相反結果;按價值披露年度上限實際上會向股東及投資者以及公司的競爭對手提供公司估計收入的指標等。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account